Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
0.6957
-0.0190 (-2.66%)
Aug 14, 2025, 11:33 AM - Market open
Xilio Therapeutics Market Cap
Xilio Therapeutics has a market cap or net worth of $36.02 million as of August 14, 2025. Its market cap has decreased by -0.41% in one year.
Market Cap
36.02M
Enterprise Value
-44.20M
1-Year Change
-0.41%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on October 22, 2021, Xilio Therapeutics's market cap has decreased from $426.71M to $36.02M, a decrease of -91.56%. That is a compound annual growth rate of -47.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 37.01M | -15.24% |
| Dec 31, 2024 | 43.66M | 188.36% |
| Dec 29, 2023 | 15.14M | -79.46% |
| Dec 30, 2022 | 73.73M | -83.14% |
| Dec 31, 2021 | 437.33M | 2.49% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |